Martinez-Molina, C.; Diaz-Torne, C.; Park, H.S.; Feliu, A.; Vidal, S.; Corominas, H.
Tofacitinib and Baricitinib in Type 2 Diabetic Patients with Rheumatoid Arthritis. Medicina 2024, 60, 360.
https://doi.org/10.3390/medicina60030360
AMA Style
Martinez-Molina C, Diaz-Torne C, Park HS, Feliu A, Vidal S, Corominas H.
Tofacitinib and Baricitinib in Type 2 Diabetic Patients with Rheumatoid Arthritis. Medicina. 2024; 60(3):360.
https://doi.org/10.3390/medicina60030360
Chicago/Turabian Style
Martinez-Molina, Cristina, Cesar Diaz-Torne, Hye S. Park, Anna Feliu, Silvia Vidal, and Hèctor Corominas.
2024. "Tofacitinib and Baricitinib in Type 2 Diabetic Patients with Rheumatoid Arthritis" Medicina 60, no. 3: 360.
https://doi.org/10.3390/medicina60030360
APA Style
Martinez-Molina, C., Diaz-Torne, C., Park, H. S., Feliu, A., Vidal, S., & Corominas, H.
(2024). Tofacitinib and Baricitinib in Type 2 Diabetic Patients with Rheumatoid Arthritis. Medicina, 60(3), 360.
https://doi.org/10.3390/medicina60030360